According to "DealStats", the private company sales database run by Business Valuation Resources, the impact of Covid-19 on the selling price of private companies has been less than expected. The results are likely skewed in that those companies most negatively impacted by the pandemic likely postponed any planned sale. But for those businesses who have sold over the past three fiscal quarters, the average "Sales Price-to-EBITDA" has averaged just a few notches from it's pre-pandemic peak of 4.3x, at around 4.1x. The low point was recorded 4 months into the pandemic, last summer, when the average EBITDA multiple dipped to 3.7x. Since, it has been trending upwards as businesses learn to adapt.
Contact us if you would like to see the impact the recent pandemic has had on the value of your business. We can provide for you a current market conditions business valuation in a timely and affordable manner. www.info@bizvalueconsulting.com
Comments